Tag: PD-L1

Home / PD-L1

Categories

Atezolizumab Plus Chemotherapy Improves Survival in Advanced-Stage Small-Cell Lung Cancer: Insights from the IMpower133 Study

IMPower133 study The IMpower133 study has brought significant advancements in the treatment of advanced-stage small-cell lung cancer (ES-SCLC). By combining atezolizumab, a type of immunotherapy, wit...
pd-l1

Pembrolizumab combination is approved by FDA for the first-line treatment of cervical cancer

Nov 2021: Pembrolizumab (Keytruda, Merck) in conjunction with chemotherapy, with or without bevacizumab, has been approved by the Food and Drug Administration for patients with persistent, recurrent, ...
pd-l1

Scan the code